ID
37279
Beskrivning
Study ID: 104864/902 Clinical Study ID: 104864/902 Study Title: An Open-Label, Single-Arm, Phase II Study of IV Weekly (Days 1 and 8 Every 21 Days) HYCAMTIN in Combination With Carboplatin (Day 1 Every 21 Days) as Second-Line Therapy in Subjects With Potentially Platinum-Sensitive Relapsed Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00316173 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: topotecan Trade Name: CARBOPLATIN Study Indication: Ovarian Cancer; Neoplasms, Ovarian
Nyckelord
Versioner (1)
- 2019-07-12 2019-07-12 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
12 juli 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
HYCAMTIN in Combination With Carboplatin in Subjects with Ovarian Cancer; NCT00316173
Study Conclusion
- StudyEvent: ODM
Beskrivning
Study Conclusion
Alias
- UMLS CUI-1
- C1707478
- UMLS CUI-2
- C0008972
Beskrivning
Completion Status, Date in time; Withdraw, Date in time
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0805732
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [2,1]
- C2349954
- UMLS CUI [2,2]
- C0011008
Beskrivning
Withdraw
Datatyp
boolean
Alias
- UMLS CUI [1]
- C2349954
Beskrivning
Withdraw, Reason and justification
Datatyp
text
Alias
- UMLS CUI [1,1]
- C2349954
- UMLS CUI [1,2]
- C0566251
Beskrivning
Withdraw, Reason and justification
Datatyp
text
Alias
- UMLS CUI [1,1]
- C2349954
- UMLS CUI [1,2]
- C0566251
Similar models
Study Conclusion
- StudyEvent: ODM
C0008972 (UMLS CUI-2)
C0011008 (UMLS CUI [1,2])
C2349954 (UMLS CUI [2,1])
C0011008 (UMLS CUI [2,2])
C0566251 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
Inga kommentarer